Developing human biomonitoring as a 21st century toolbox within the European exposure science strategy 2020–2030
2022; Elsevier BV; Volume: 168; Linguagem: Inglês
10.1016/j.envint.2022.107476
ISSN1873-6750
AutoresMaryam Zare Jeddi, Nancy B. Hopf, Henriqueta Louro, Susana Viegas, Karen S. Galea, Robert Pasanen‐Kase, Tiina Santonen, Vicente Mustieles, Mariana F. Fernández, Hans Verhagen, Stephanie K. Bopp, Jean‐Philippe Antignac, Arthur David, Hans Mol, Robert Barouki, Karine Audouze, Radu Corneliu Duca, Peter Fantke, Paul T.J. Scheepers, Manosij Ghosh, An Van Nieuwenhuyse, Joana Lobo Vicente, Xenia Trier, Loïc Rambaud, Clémence Fillol, Sébastien Denys, André Conrad, Marike Kolossa‐Gehring, Alicia Paini, Jon A. Arnot, F. Schulze, Kate Jones, Ovnair Sepai, Imran Ali, Lorraine Brennan, Emilio Benfenati, Francesco Cubadda, Alberto Mantovani, Alena Bartoňová, Alison Connolly, Jaroslav Slobodnı́k, Yuri Bruinen de Bruin, Jacob van Klaveren, Nicole Palmen, Hubert Dirven, Trine Husøy, Cathrine Thomsen, Ana Virgolino, Martin Röösli, Timothy W. Gant, Natalie von Goetz, Jos Bessems,
Tópico(s)Effects and risks of endocrine disrupting chemicals
Referência(s)